514 related articles for article (PubMed ID: 15830829)
1. Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
Benazzi F
Can J Psychiatry; 2005 Mar; 50(3):184. PubMed ID: 15830829
[No Abstract] [Full Text] [Related]
2. Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
Al-Adwani A
Can J Psychiatry; 2005 Nov; 50(13):877; author reply 877-8. PubMed ID: 16483124
[No Abstract] [Full Text] [Related]
3. Safety and tolerability of the new antidepressants.
Nelson JC
J Clin Psychiatry; 1997; 58 Suppl 6():26-31. PubMed ID: 9227670
[TBL] [Abstract][Full Text] [Related]
4. [Applications and safety of modern antidepressants in patients with liver diseases].
Dubarek W; Kucia K
Wiad Lek; 2007; 60(1-2):28-33. PubMed ID: 17607965
[TBL] [Abstract][Full Text] [Related]
5. Dual action antidepressants and some important considerations.
Gupta RK; Tiller JW; Burrows GD
Aust N Z J Psychiatry; 2003 Apr; 37(2):190-5. PubMed ID: 12656958
[TBL] [Abstract][Full Text] [Related]
6. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
[TBL] [Abstract][Full Text] [Related]
7. [Combining venlafaxine and mirtazapine for the treatment of major depression with dysthymia--"double depression"].
Ladeira RB; Cunha FT; Salgado JV; Teixeira AL; Nicolato R
Braz J Psychiatry; 2008 Sep; 30(3):299-300. PubMed ID: 18833439
[No Abstract] [Full Text] [Related]
8. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
Kennedy SH; Andersen HF; Lam RW
J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
[TBL] [Abstract][Full Text] [Related]
9. Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine.
Masand PS; Gupta S
Ann Clin Psychiatry; 2002 Sep; 14(3):175-82. PubMed ID: 12585567
[TBL] [Abstract][Full Text] [Related]
10. Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis.
Gartlehner G; Hansen RA; Carey TS; Lohr KN; Gaynes BN; Randolph LC
Int Clin Psychopharmacol; 2005 Mar; 20(2):59-69. PubMed ID: 15729080
[TBL] [Abstract][Full Text] [Related]
11. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
Lenox-Smith AJ; Jiang Q
Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
[TBL] [Abstract][Full Text] [Related]
12. Escitalopram versus venlafaxine XR in the treatment of depression.
Montgomery SA; Andersen HF
Int Clin Psychopharmacol; 2006 Sep; 21(5):297-309. PubMed ID: 16877901
[TBL] [Abstract][Full Text] [Related]
13. SIADH with multiple antidepressants in a geriatric patient.
Blass DM; Pearson VE
J Clin Psychiatry; 2000 Jun; 61(6):448-9. PubMed ID: 10901346
[No Abstract] [Full Text] [Related]
14. Synergistic benefits of serotonin and noradrenaline reuptake inhibition.
Nelson JC
Depress Anxiety; 1998; 7 Suppl 1():5-6. PubMed ID: 9597344
[No Abstract] [Full Text] [Related]
15. Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients.
Deuschle M; Angermeier T; Westphal S; Lederbogen F; Gilles M; Frankhauser P; Schilling C; Onken V; Weber-Hamann B; Kopf D
Psychother Psychosom; 2010; 79(2):123-5. PubMed ID: 20090399
[No Abstract] [Full Text] [Related]
16. Venlafaxine plus mirtazapine as first-line treatment for melancholia: preliminary results.
Ruiz-Doblado S; Rueda-Villar T; Zurita-Gotor P; Sanz-Cortes S
J Psychopharmacol; 2010 Dec; 24(12):1837. PubMed ID: 21138931
[No Abstract] [Full Text] [Related]
17. Agranulocytosis during treatment with mianserin and venlafaxine.
Lucht MJ; Kleinschmidt R; Maier W; Rietschel M
J Clin Psychopharmacol; 2000 Aug; 20(4):490-1. PubMed ID: 10917414
[No Abstract] [Full Text] [Related]
18. Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
Bateman DN; Chick J; Good AM; Kelly CA; Masterton G
Eur J Clin Pharmacol; 2004 May; 60(3):221-4. PubMed ID: 15083251
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.
Bobo WV; Chen H; Trivedi MH; Stewart JW; Nierenberg AA; Fava M; Kurian BT; Warden D; Morris DW; Luther JF; Husain MM; Cook IA; Lesser IM; Kornstein SG; Wisniewski SR; Rush AJ; Shelton RC
J Affect Disord; 2011 Oct; 133(3):467-76. PubMed ID: 21601287
[TBL] [Abstract][Full Text] [Related]
20. A possible case of venlafaxine-induced Stevens-Johnson syndrome.
Weiss NT; Jones L; Chamberlain JC
J Clin Psychiatry; 2004 Oct; 65(10):1431-3. PubMed ID: 15491252
[No Abstract] [Full Text] [Related]
[Next] [New Search]